EMEA-000309-PIP02-14
Key facts
Invented name |
RoActemra
|
Active substance |
tocilizumab
|
Therapeutic area |
Immunology-Rheumatology-Transplantation
|
Decision number |
P/0135/2015
|
PIP number |
EMEA-000309-PIP02-14
|
Pharmaceutical form(s) |
Solution for injection in pre-filled syringe
|
Condition(s) / indication(s) |
Treatment of vasculitides
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Roche Registration Limited
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|